Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Manifesto Developed for Medical Research in Europe

By HospiMedica staff writers
Posted on 24 Dec 2007
Public spending on medical research in Europe should be doubled over the next 10 years to ensure the health and welfare of Europe's citizens and to nurture a thriving medical research industry, according to an influential panel of scientists. More...
Moreover, the panel reported that there should be greater collaboration between European institutions in medical research and improved career paths for medical scientists.

These are some of the core conclusions presented in a wide-ranging White Paper (policy document) released in December 2007 by the European Medical Research Councils (EMRC; Strasbourg, France)--the European Science Foundation's (ESF) membership organization for all medical research councils in Europe.

The EMRC White Paper, "Present Status and Future Strategy for Medical Research in Europe,” was presented at a meeting held in Brussels, Belgium, on December 6, 2007, and was co-chaired by Janez Potocnik, European Union (EU) Commissioner for Science and Research, and Prof. Liselotte Højgaard, chair of the EMRC. The White Paper is the result of a comprehensive analysis of the current state of medical research within Europe compared with its global competitors, together with an assessment of new challenges facing Europe's citizens, including changing patterns of disease, environmental issues including global warming, and changing demographic factors such as an ageing population.

The White Paper makes several key recommendations aimed at strengthening and improving medical research in Europe. These include: 1) implementation of best practice for funding and performing medical research--with distribution of funding in competition based on excellence and evaluated by peer review; 2) strengthened collaboration and coordination of medical research in Europe through the EMRC and its membership organizations, via the European Commission, the European Research Council, and the learned medical societies; 3) revision of EC directives related to medical research; 4) implementation of equal opportunities for all researchers; and 5) a doubling of public funding of medical research in Europe within the next ten years--to a minimum of 0.25% of gross domestic product (GDP).

The EMRC White Paper recognizes that the newer countries of the European Union require extra investment in research infrastructure to bring their facilities to the level of the older countries within the union.

Prof. Højgaard, director and professor of clinical physiology, nuclear medicine and positron emission tomography (PET) at Rigshospitalet-University of Copenhagen (Denmark), said, "We believe that this White Paper presents a powerful case for the future strategy of medical research in Europe, which will benefit society in many ways and will improve the quality of life for the citizens of Europe and the rest of the world and meet the difficult challenges we are facing. A strong base in medical research will also lay the foundations for a more successful medical industry in Europe.”

Commissioner Janez Potocnik for Science and Research remarked, "What Europe needs is a more coherent, strategic approach to research at European level. This was the driving philosophy behind our Green Paper on the European Research Area, and one the EMRC have taken up in their paper. That national medical research councils are teaming up to better organize medical research in Europe is a very significant signal. I look forward to exploring the EMRC's ideas and help them deliver on their objectives.”

The heads of medical research councils in Europe, editors-in-chief of medical journals, and the presidents of medical learned societies will be invited to debate the White Paper and propose actions to bring the EMRC strategy to fruition at a briefing conference on January 30, 2008, in Frankfurt, Germany. The EMRC White Paper may be dowloaded from the Council's Website.

The ESF was established in 1974 to create a common European platform for cross-border cooperation in all aspects of scientific research. Headquartered in Strasbourg with offices in Brussels and Ostend, Belgium, the ESF's membership comprises 78 national funding agencies, research performing agencies, and academies from 30 European nations. The Foundation's independence allows the ESF to objectively represent the priorities of all these members.

The EMRC is the European Science Foundation's membership organization for all medical research councils in Europe. The mission of the EMRC is to promote innovative medical research and its clinical application towards improved human health. EMRC disseminates knowledge and promotes the socio-economic value of medical research to the general public and the decision makers.


Related Links:
European Medical Research Councils
EMRC White Paper

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.